Direct-care growth and LINAC volume gains are offset by falling leasing revenue and unresolved lender covenant risk.
| Quarter | Q4 FY25 |
|---|---|
| Call date | 2026-04-01 |
| Length | 25 minutes |
| EPS | $-0.09 |
| Revenue | $7.1M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
All AMS earnings ยท Back to AMS overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.